This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Lorans M, Dow E, Macrae FA, Winship IM, Buchanan DD. Update on hereditary colorectal cancer: Improving the clinical utility of multigene panel testing. Clin Colorectal Cancer. 2018; 17(2): e293-e305.LoransMDowEMacraeFAWinshipIMBuchananDDUpdate on hereditary colorectal cancer: Improving the clinical utility of multigene panel testing2018172e293e30510.1016/j.clcc.2018.01.00129454559Search in Google Scholar
Loomans-Kropp HA, Umar A. Cancer prevention and screening: The next step in the era of precision medicine. NPJ Precis Oncol. 2019; 3: 3.Loomans-KroppHAUmarACancer prevention and screening: The next step in the era of precision medicine20193310.1038/s41698-018-0075-9634990130701196Search in Google Scholar
Boland PM, Yurgelun MB, Boland CR. Recent progress in Lynch syndrome and other familial colorectal cancer syndromes. CA Cancer J Clin. 2018; 68(3): 217-231.BolandPMYurgelunMBBolandCRRecent progress in Lynch syndrome and other familial colorectal cancer syndromes201868321723110.3322/caac.21448598069229485237Search in Google Scholar
Valle L. Genetic predisposition to colorectal cancer: Where we stand and future perspectives. World J Gastroenterol. 2014; 20(29): 9828-9849.ValleLGenetic predisposition to colorectal cancer: Where we stand and future perspectives201420299828984910.3748/wjg.v20.i29.9828412336625110415Search in Google Scholar
Hsu L, Jeon J, Brenner H, Gruber SB, Schoen RE, Berndt SI, et al. Colorectal Transdisciplinary (CORECT) Study; Genetic and Epidemiology of Colorectal Cancer Consortium (GECCO). A model to determine colorectal cancer risk using common genetic susceptibility loci. Gastroenterology. 2015; 148(7): 1330-1339.e14.HsuLJeonJBrennerHGruberSBSchoenREBerndtSIColorectal Transdisciplinary (CORECT) Study; Genetic and Epidemiology of Colorectal Cancer Consortium (GECCO). A model to determine colorectal cancer risk using common genetic susceptibility loci201514871330133910.1053/j.gastro.2015.02.010444619325683114Search in Google Scholar
Hiljadnikova-Bajro M, Josifovski T, Panovski M, Dimovski AJ. A novel germline MLH1 mutation causing Lynch Syndrome in patients from the Republic of Macedonia. Croat Med J. 2012; 53(5): 496-501.Hiljadnikova-BajroMJosifovskiTPanovskiMDimovskiAJA novel germline MLH1 mutation causing Lynch Syndrome in patients from the Republic of Macedonia201253549650110.3325/cmj.2012.53.496349046023100212Search in Google Scholar
Stefanovska AM, Josifovski T, Panovski M, Jasar D, Zografski G, Efremov GD, et al. Molecular characterization of familial adenomatous polyposis in the Republic of Macedonia. Balkan J Med Genet. 2004; 7(1&2): 33-40.StefanovskaAMJosifovskiTPanovskiMJasarDZografskiGEfremovGDMolecular characterization of familial adenomatous polyposis in the Republic of Macedonia200471&23340Search in Google Scholar
Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert B, et al. Colorectal cancer screening in Europe. World J Gastroenterol 2009; 15(47): 5907-5915.ZavoralMSuchanekSZavadaFDusekLMuzikJSeifertBColorectal cancer screening in Europe200915475907591510.3748/wjg.15.5907279517720014454Search in Google Scholar
Pérez-Carbonell L, Alenda C, Payá A, Castillejo A, Barberá VM, Guillén C, et al Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome. J Mol Diagn. 2010; 12(4): 498-504.Pérez-CarbonellLAlendaCPayáACastillejoABarberáVMGuillénCMethylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome201012449850410.2353/jmoldx.2010.090212289363520489114Search in Google Scholar
Wang K, Li M, Hakonarson H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38(16):e164.WangKLiMHakonarsonHANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data20103816e16410.1093/nar/gkq603293820120601685Search in Google Scholar
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405-424.RichardsSAzizNBaleSBickDDasSGastier-FosterJStandards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology201517540542410.1038/gim.2015.30454475325741868Search in Google Scholar
Ma H, Difazio S. An efficient method for purification of PCR products for sequencing. BioTechniques. 2008; 44(7): 921-923.MaHDifazioSAn efficient method for purification of PCR products for sequencing200844792192310.2144/00011280918533902Search in Google Scholar
Chubb D, Broderick P, Frampton M, Kinnersley B, Sherborne A, Penegar S, et al Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing. J Clin Oncol. 2015; 33(5): 426-432.ChubbDBroderickPFramptonMKinnersleyBSherborneAPenegarSGenetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing201533542643210.1200/JCO.2014.56.568925559809Search in Google Scholar
Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K, et al Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 2017; 3(4): 464-471.PearlmanRFrankelWLSwansonBZhaoWYilmazAMillerKPrevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer20173446447110.1001/jamaoncol.2016.5194556417927978560Search in Google Scholar
Liu B, Parsons RE, Hamilton SR, Petersen GM, Lynch HT, Watson P, et al hMSH2 Mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res. 1994; 54(17): 4590-4594.LiuBParsonsREHamiltonSRPetersenGMLynchHTWatsonPhMSH2 Mutations in hereditary nonpolyposis colorectal cancer kindreds1994541745904594Search in Google Scholar
Vasen HF, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I, et al Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet. 2007; 44(6): 353-362.VasenHFMosleinGAlonsoABernsteinIBertarioLBlancoIGuidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)200744635336210.1136/jmg.2007.048991274087717327285Search in Google Scholar
Khoo SK, Giraud S, Kahnoski K, Chen J, Motorna O, Nickolov R, et al Clinical and genetic studies of Birt-Hogg-Dubé syndrome. J Med Genet. 2002; 39(12): 906-912.KhooSKGiraudSKahnoskiKChenJMotornaONickolovRClinical and genetic studies of Birt-Hogg-Dubé syndrome2002391290691210.1136/jmg.39.12.906175721912471204Search in Google Scholar
Shin JH, Shin YK, Ku JL, Jeong SY, Hong SH, Park SY, et al Mutations of the Birt-Hogg-Dube (BHD) gene in sporadic colorectal carcinomas and colorectal carcinoma cell lines with microsatellite instability. J Med Genet. 2003; 40(5):364-367.ShinJHShinYKKuJLJeongSYHongSHParkSYMutations of the Birt-Hogg-Dube (BHD) gene in sporadic colorectal carcinomas and colorectal carcinoma cell lines with microsatellite instability200340536436710.1136/jmg.40.5.364173547112746401Search in Google Scholar
Nahorski MS, Lim DHK, Martin L, Gille JJP, McKay K, Rehal PK, et al Investigation of the Birt-Hogg-Dubé tumour suppressor gene (<em>FLCN</em>) in familial and sporadic colorectal cancer. J Med Genet. 2010; 47(6): 385-390.NahorskiMSLimDHKMartinLGilleJJPMcKayKRehalPKInvestigation of the Birt-Hogg-Dubé tumour suppressor gene (<em>FLCN</em>) in familial and sporadic colorectal cancer201047638539010.1136/jmg.2009.07330420522427Search in Google Scholar
Kashiwada T, Shimizu H, Tamura K, Seyama K, Horie Y, Mizoo A. Birt-Hogg-Dube syndrome and familial adenomatous polyposis: An association or a coincidence? Intern Med. 2012; 51(13): 1789-1792.KashiwadaTShimizuHTamuraKSeyamaKHorieYMizooABirt-Hogg-Dube syndrome and familial adenomatous polyposis: An association or a coincidence?201251131789179210.2169/internalmedicine.51.723922790147Search in Google Scholar
Stoffel EM, Koeppe E, Everett J, Ulintz P, Kiel M, Osborne J, et al Germline genetic features of young individuals with colorectal cancer. Gastroenterology. 2018; 154(4): 897-905.e1.StoffelEMKoeppeEEverettJUlintzPKielMOsborneJGermline genetic features of young individuals with colorectal cancer2018154489790510.1053/j.gastro.2017.11.004584742629146522Search in Google Scholar
Gupta S, Provenzale D, Llor X, Halverson AL, Grady W, Chung DC, et al NCCN Guidelines insights: Genetic/familial high-risk assessment: Colorectal, Version 2.2019. J Natl Compr Canc Netw. 2019; 17(9): 1032-1041. doi: 10.6004/jnccn.2019.0044.GuptaSProvenzaleDLlorXHalversonALGradyWChungDCNCCN Guidelines insights: Genetic/familial high-risk assessment: Colorectal, Version 2.201920191791032104110.6004/jnccn.2019.004431487681Open DOISearch in Google Scholar
Grolleman JE, de Voer RM, Elsayed FA, Nielsen M, Weren RDA, Palles C, et al Mutational signature analysis reveals NTHL1 deficiency to cause a multi-tumor phenotype. Cancer Cell. 2019; 35(2): 256-266. e5.(?)GrollemanJEde VoerRMElsayedFANielsenMWerenRDAPallesCMutational signature analysis reveals NTHL1 deficiency to cause a multi-tumor phenotype2019352256266e5.(?)10.1016/j.ccell.2018.12.01130753826Search in Google Scholar
Valle L, de Voer RM, Goldberg Y, Sjursen W, Forsti A, Ruiz-Ponte C, et al Update on genetic predisposition to colorectal cancer and polyposis. Mol Aspects Med. 2019; 69:10-26. doi: 10.1016/j.mam.2019.03.001.ValleLde VoerRMGoldbergYSjursenWForstiARuiz-PonteCUpdate on genetic predisposition to colorectal cancer and polyposis201969102610.1016/j.mam.2019.03.00130862463Open DOISearch in Google Scholar
Blount J, Prakash A. The changing landscape of Lynch syndrome due to PMS2 mutations. Clin Genet. 2018; 94(1): 61-69.BlountJPrakashAThe changing landscape of Lynch syndrome due to PMS2 mutations2018941616910.1111/cge.13205599563729286535Search in Google Scholar
Pino MS, Mino-Kenudson M, Wildemore BM, Ganguly A, Batten J, Sperduti I, et al Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas. J Mol Diagn. 2009; 11(3): 238-247.PinoMSMino-KenudsonMWildemoreBMGangulyABattenJSperdutiIDeficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas200911323824710.2353/jmoldx.2009.080142267134119324997Search in Google Scholar
Berends MJ, Wu Y, Sijmons RH, Mensink RG, van der Sluis T, Hordijk-Hos JM, et al Molecular and clinical characteristics of MSH6 variants: An analysis of 25 index carriers of a germline variant. Am J Hum Genet. 2002; 70(1): 26-37.BerendsMJWuYSijmonsRHMensinkRGvan der SluisTHordijk-HosJMMolecular and clinical characteristics of MSH6 variants: An analysis of 25 index carriers of a germline variant2002701263710.1086/33794438489611709755Search in Google Scholar
Yurgelun MB, Allen B, Kaldate RR, Bowles KR, Judkins T, Kaushik P, et al Identification of a variety of mutations in cancer predisposition genes in patients with suspected Lynch syndrome. Gastroenterology. 2015; 149(3):604-613.e20.YurgelunMBAllenBKaldateRRBowlesKRJudkinsTKaushikPIdentification of a variety of mutations in cancer predisposition genes in patients with suspected Lynch syndrome2015149360461310.1053/j.gastro.2015.05.006455053725980754Search in Google Scholar
Reilly NM, Novara L, Di Nicolantonio F, Bardelli A. Exploiting DNA repair defects in colorectal cancer. Mol Oncol. 2019; 13(4): 681-700.ReillyNMNovaraLDi NicolantonioFBardelliAExploiting DNA repair defects in colorectal cancer201913468170010.1002/1878-0261.12467644192530714316Search in Google Scholar
AlDubayan SH, Giannakis M, Moore ND, Han GC, Reardon B, Hamada T, et al Inherited DNA-repair defects in colorectal cancer. Am J Hum Genet. 2018; 102(3): 401-414.AlDubayanSHGiannakisMMooreNDHanGCReardonBHamadaTInherited DNA-repair defects in colorectal cancer2018102340141410.1016/j.ajhg.2018.01.018598528029478780Search in Google Scholar
Nielsen FC, van Overeem Hansen T, Sørensen CS. Hereditary breast and ovarian cancer: New genes in confined pathways. Nat Rev Cancer. 2016; 16(9): 599-612.NielsenFCvan Overeem HansenTSørensenCSHereditary breast and ovarian cancer: New genes in confined pathways201616959961210.1038/nrc.2016.7227515922Search in Google Scholar
Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, et al Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas. Cell Rep. 2019; 23(1): 239-254.e6.KnijnenburgTAWangLZimmermannMTChambweNGaoGFCherniackADGenomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas201923123925410.1016/j.celrep.2018.03.076596150329617664Search in Google Scholar
Mateo J, Carreira S, Sandhu S, Miranda S, Mossop H, Perez-Lopez R, et al DNA-repair defects and olaparib in metastatic prostate cancer. N Engl J Med. 2015; 373(18): 1697-1708.MateoJCarreiraSSandhuSMirandaSMossopHPerez-LopezRDNA-repair defects and olaparib in metastatic prostate cancer2015373181697170810.1056/NEJMoa1506859Search in Google Scholar
Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, et al Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: A proof-of-concept trial. Lancet. 2010; 376(9737): 235-244.TuttARobsonMGarberJEDomchekSMAudehMWWeitzelJNOral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: A proof-of-concept trial2010376973723524410.1016/S0140-6736(10)60892-6Search in Google Scholar
Pishvaian MJ, Blais EM, Brody JR, Rahib L, Lyons E, Arbeloa PD, et al Outcomes in patients with pancreatic adenocarcinoma with genetic mutations in DNA damage response pathways: Results from the Know Your Tumor Program. JCO Precision Oncology. 2019; 37:(4 Suppl): 191.PishvaianMJBlaisEMBrodyJRRahibLLyonsEArbeloaPDOutcomes in patients with pancreatic adenocarcinoma with genetic mutations in DNA damage response pathways: Results from the Know Your Tumor Program2019374 Suppl19110.1200/PO.19.0011535100730Search in Google Scholar